[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2004012701A2 - NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. - Google Patents

NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. Download PDF

Info

Publication number
WO2004012701A2
WO2004012701A2 PCT/IN2003/000263 IN0300263W WO2004012701A2 WO 2004012701 A2 WO2004012701 A2 WO 2004012701A2 IN 0300263 W IN0300263 W IN 0300263W WO 2004012701 A2 WO2004012701 A2 WO 2004012701A2
Authority
WO
WIPO (PCT)
Prior art keywords
enteric
novel
solution
coating
cap
Prior art date
Application number
PCT/IN2003/000263
Other languages
French (fr)
Other versions
WO2004012701A3 (en
Inventor
Ajit Singh
Meena Parashuraman
Original Assignee
Scitech Centre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scitech Centre filed Critical Scitech Centre
Priority to AU2003274683A priority Critical patent/AU2003274683A1/en
Publication of WO2004012701A2 publication Critical patent/WO2004012701A2/en
Publication of WO2004012701A3 publication Critical patent/WO2004012701A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material

Definitions

  • the present invention relates to enteric polymeric capsules and more
  • capsules for pharmaceutical applications consists of capsule
  • Such capsules contain two parts: a capsule
  • plasticizer particularly triethyl citrate
  • JP62016432A2 titled ENTERIC COATING COMPOSITION also teaches
  • composition as disclosed by JP62016432A2 consists essentially of a
  • composition Various plasticizers are known in the art for use in the capsules.
  • plasticizers are known in the art for use in the capsules.
  • time is sometimes recognized with time. If triacetin is used, there is a problem of acetic acid smell formation with time.
  • Triethyl citrate as plasticizer in the shell composition.
  • the soft gelatin capsule is prepared along with the inside
  • the present invented capsule can be supplied as empty
  • German Patent No. DE 322 22476 describes a pharmaceutical
  • composition in which a soft gelatin capsule that is resistant to digestive
  • crotonic acid copolymer and an alkali metal salt, ammonia salt, or amino
  • the capsules are further treated
  • polymer in the shell reacts with the active ingredient and reduces the
  • plasticizer glycerin and propylene glycol as plasticizers. Further, the patent claims
  • plasticizer is not just optional, but it is mandatory requirement in
  • the primary object of the present invention is to overcome the above
  • Still most important object of the present invention is to eliminate the step
  • Another object of the present invention is to provide a process for
  • the present invention essentially resides in a surprising discovery that triethyl citrate (TEC) in particular and other plasticizers in general when
  • polymeric composition especially gelatin and other compositions like HPMC, modified starch, modified polyvinyl acetate
  • substances which can substitute triethyl citrate are dibutyl pthalate, diethyl pthalate, benzyl phenyl formate, sorbitol and others.
  • the present invention gives an answer to the coating problems and gives
  • the present invention comprises the use of enteric polymers such as
  • methacrylic acid copolymer cellulose acetate phthalate, hydroxy propyl methylcellulose and hydroxypropyl methylcellulose phthalate, Polyvinyl acetate phthalate and other gastro resistant polymers and combinations thereof.
  • the present invention provides a novel pH dependent robust enteric polymeric container consisting of a body and a cap such as hard capsules and the like and a process of manufacturing the same comprising the steps of:
  • the alkaline solution used for neutralizing enteric polymer is prepared by
  • the enteric polymer is selected in the range 1 % to 60%.
  • the plasticizer is selected in the range of 0.5% to 7% preferably 1 to 5%.
  • the aqueous gelatin solution is in the range of 3 to 35% preferably in the range 5 to 25%.
  • the gelatin solution was added at a temperature in the range 45°C to 55° C, preferably in the range 46°C to 52°C.
  • the enteric polymer is selected from a group consisting methacrylic acid
  • Methacrylic acid copolymer comprises 5% W/W to 60% W/W preferably it
  • Cellulose acetate phthalate is to be used in the range of 2 to 12%,
  • Hydroxypropyl methylcellulose pthalate is to be used within the range of 1
  • Gelatin is used in the range of 3 to 35% in the composition, preferably
  • Colourants surfactants, opacifiers, silicon dioxide, preservatives like
  • capsule body shell and cap shell like any other regular capsule.
  • the containers may or may not be sealed either by applying an enteric
  • the above said containers can be printed both axially and radially in one
  • the present invention also teaches an improved process for reducing the
  • Triethyl citrate to optimize the correct desired concentration.
  • citrate was used in 0.5, 1 .0, 1 .5, 2, 3, 4, 5, 6 and 7% addition level.
  • Triethyl citrate finds use in this invention as mentioned herein:
  • Methacrylic acid polymer was added in ammoniated water and stirred for
  • the TEC floats on top and does not give uniform solution.
  • the containers of the present invention are made by the conventional dip
  • the containers such as injection- moulding and the like.
  • Methacrylic acid copolymer 7.86 g.
  • Methacrylic acid copolymer 13.79 g.
  • Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Gelatin solution is added to the polymer solution under stirring at temp 52°C and deareate the final solution at temp 52°C.
  • Hard gelatin capsules are molded in conventional dip molding process. Propylene glycol is a plasticizer and gives capsules that are not sturdy. The capsules were soft and pliable.
  • Methacrylic acid copolymer C To Methacrylic acid copolymer C Suspension slowly add ammonia solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process.
  • Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C.
  • Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle for 10 days and retained the mechanical strength. But cellulose acetate phthalate (CAP) did not give good result in stability studies.
  • Example-16
  • Example 20 Added water to sodium bicarbonate and mixed, well. Added methacrylic acid copolymer to the above and stirred. Gelatin solution was added to above solution and mixed well. De-aerated the solution at 40 deg. C on a water bath. Films were prepared before dip molding the capsules to check the disintegration properties. The films did not disintegrate in gastric pH for 2 hrs. This passes the enteric test. The films were soft without any brittleness. Example 20
  • HPMCP was dispersed in water and ammonia was added to solubilise it.
  • HPMCP was dispersed in water and ammonia was added to solubilise it. Carrageenan and potassium chloride was added and gelatin solution was added to the above. A film was prepared to check the disintegration properties. The film was very BRITTLE and did not dissolve in gastric pH for 2 hours.
  • Carrageenan ( gelling aid ) 0.5 g.
  • Potassium chloride 0.04 g.
  • HPMCP was dispersed in water and ammonia was added to solubilise it.
  • Carrageenan and potassium chloride was added and gelatin solution was added to the above.
  • a film was prepared to check the disintegration properties. The film was very BRITTLE and did not dissolve in gastric pH for 2 hours. Study of Brittleness of Enteric capsules with different concentrations of Triethyl citrate.
  • Brittleness Take 100 capsule shells devoid of long short, broken or separated ones, place each shell on a smooth hard surface. Using a brass rod of 150mm length and 25 mm diameter and weighing approximately 0.5 kg, press the entire length of the shell until the sides meet. Repeat with another 99 shells. Not more than two shells crack, ship or break. If more than two but less than six shells fail to comply with the test, repeat the test with another 100 shells taken at random. The sample being examined if not more than six out of 200 shells fail to comply with the test.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to a novel pH dependent robust enteric polymeric containers such as hard capsules and a process of manufacturing the same wherein polymeric containers are characterized by having improved elasticity containing right proportion of plasticizers within the capsule shell composition rather than the coating composition.

Description

TITLE OF INVENTION
NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
The present invention relates to enteric polymeric capsules and more
particularly to two-piece hard capsules for pharmaceutical, nutraceuticals,
herbal, and the like applications.
At present, capsules for pharmaceutical applications consists of capsule
shell and a coating there on. Such capsules contain two parts: a capsule
body and a cap.
Conventionally, made enteric hard gelatin capsules are somewhat brittle
in nature, thus creating a major problem on the capsule filling machines.
It is known in the art to use plasticizer particularly triethyl citrate as a
stabilizing agent with regard to gelatin capsules. Japanese Patent No.
JP62016432A2 titled ENTERIC COATING COMPOSITION also teaches
the use of triethyl citrate as a stabilizing agent. The enteric coating
composition as disclosed by JP62016432A2 consists essentially of a
water- dispersible copolymer obtained by emulsion polymerizing of ethyl
acrylate with methacrylic acid and triethyl citrate. Although the above-
mentioned water - dispersible copolymer is used in an enteric coating, the
addition of a plasticizer is indispensable to prevent the cracking and
embrittling of the coating layer. However the above mentioned Japanese
patent uses triethyl citrate in mixed form with the enteric coating
composition. Various plasticizers are known in the art for use in the capsules. In the
case of the polyethylene glycol as plasticizer, the delay in disintegration
time is sometimes recognized with time. If triacetin is used, there is a problem of acetic acid smell formation with time.
Soft Gelatin capsules known in the art are found to use Glycerol
combined with Triethyl citrate as plasticizer in the shell composition.
Moreover the soft gelatin capsule is prepared along with the inside
content. The present invented capsule can be supplied as empty
containers with enteric properties where any kind of material can be filled
inside the container.
German Patent No. DE 322 22476 describes a pharmaceutical
composition in which a soft gelatin capsule that is resistant to digestive
juice whose wall includes gelatin mass which contain polyvinyl acetate
phthalate, hydroxypropyl methylcellulose phthalate or a vinyl acetate or
crotonic acid copolymer and an alkali metal salt, ammonia salt, or amino
salt of the same in their wall, and which released its contents readily in
the intestines within the prescribed time. The capsules are further treated
on the surface with an aldehyde-coating agent. However, this
composition has a disadvantage that the free acidic groups of the
polymer in the shell reacts with the active ingredient and reduces the
efficacy of the product during its storage or shelf life period.
US Patent No. 4, 138, 013 describes a hard-shell pharmaceutical capsule
being characterized by relative freedom from brittleness and by
substantial absence of degradation on exposure to artificial gastric juice
for 120 minutes, and the body and cap portions being formed by the dip- molding technique from a homogeneous film-forming composition
comprising hydroxypropyl methylcellulose and an ammonium salt of cellulose acetate phthalate polymer or gelatin and an ammonium salt of a
copolymer of methacrylic acid and methacrylic acid ester, optionally with
the inclusion of plasticizer and/or coloring agents. The patent claims glycerin and propylene glycol as plasticizers. Further, the patent claims
that use of plasicizers is optional. The present invention shows that the
use of plasticizer is not just optional, but it is mandatory requirement in
view of avoiding brittleness. Moreover, the present invention describes
the use of triethyl citrate as plasticizer in a particular proportion to
overcome the brittleness of the capsule since the use of propylene glycol
and glycerin as plasticizers renders the capsule soft and pliable, and the
capsules become non-sturdy.
OBJECTS OF THE INVENTION
The primary object of the present invention is to overcome the above
problems and particularly the problem of brittleness and also to make the
capsule commercially feasible.
Still most important object of the present invention is to eliminate the step
of coating the capsules as practiced at present thus saving in cost of
manufacture and simultaneously reducing its undesirable brittleness to
the desired extent.
Another object of the present invention is to provide a process for
producing the capsule without conventional coating wherein desired plasticity of the capsule is maintained wherein use of glycerol or propylene glycol are done away with.
SUMMARY AND DETAILED DESCRIPTION OF THE INVENTION
The present invention essentially resides in a surprising discovery that triethyl citrate (TEC) in particular and other plasticizers in general when
used with polymeric composition, especially gelatin and other compositions like HPMC, modified starch, modified polyvinyl acetate
(PVA), carrageenan or any other suitable material to make the enteric hard capsules the step of providing enteric coating can be dispensed with
still retaining the desired enteric property of the capsules and also
undesired brittleness of the capsules can be eliminated. The other
substances which can substitute triethyl citrate are dibutyl pthalate, diethyl pthalate, benzyl phenyl formate, sorbitol and others.
In commerce, coating of tablets and capsules are the general methods
adapted for enteric or controlled dissolution properties. Uniform coating of
the polymer and uniform release of the drug are the most common
problems encountered. Some of the coated tablets when tested for the
release of the drug in gastric medium shows variation from 4% to 12.8% . The present invention gives an answer to the coating problems and gives
a ready to use enteric container which releases only up to 2% of the drug
in the gastric medium.
The present invention comprises the use of enteric polymers such as
methacrylic acid copolymer, cellulose acetate phthalate, hydroxy propyl methylcellulose and hydroxypropyl methylcellulose phthalate, Polyvinyl acetate phthalate and other gastro resistant polymers and combinations thereof.
The present invention provides a novel pH dependent robust enteric polymeric container consisting of a body and a cap such as hard capsules and the like and a process of manufacturing the same comprising the steps of:
(a) neutralizing enteric polymer slowly in alkaline solution under stirring,
(b) de-aeration of the solution on the water bath,
(c) adding plasticizer to the polymer solution under stirring and homogenized,
(d) adding gelatin solution to the polymer solution under stirring at
desired temperature,
(e) de-aeration of the final solution at desired temperature,
(f) dipping and molding the capsule, by conventional process known
in the art.
The alkaline solution used for neutralizing enteric polymer is prepared by
adding water to a base like ammonia, sodium carbonate, sodium
bicarbonate and like under stirring.
The enteric polymer is selected in the range 1 % to 60%.
The plasticizer is selected in the range of 0.5% to 7% preferably 1 to 5%. The aqueous gelatin solution is in the range of 3 to 35% preferably in the range 5 to 25%.
The gelatin solution was added at a temperature in the range 45°C to 55° C, preferably in the range 46°C to 52°C.
The enteric polymer is selected from a group consisting methacrylic acid
copolymer in the range .5% to 60% W/W, Cellulose acetate phthalate in
the range of 2 to 12% preferably 3 to 8%, hydroxypropyl methylcellulose
phthalate in the range of 1 to 20%.
Methacrylic acid copolymer comprises 5% W/W to 60% W/W preferably it
within the range 8% to 20%, more preferably within the range 12% to
18%.
Cellulose acetate phthalate (CAP) is to be used in the range of 2 to 12%,
more preferably within the range 3% to 8%.
Hydroxypropyl methylcellulose pthalate is to be used within the range of 1
to 20%..
Gelatin is used in the range of 3 to 35% in the composition, preferably
should be in range of 5 to 25%.
Colourants, surfactants, opacifiers, silicon dioxide, preservatives like
parabens, acetic acid, sweeteners, flavours can be incorporated in the
capsule body shell and cap shell like any other regular capsule.
The containers may or may not be sealed either by applying an enteric
polymeric band around the container or by sealing the cap and body by
any other suitable process. The above said containers can be printed both axially and radially in one
or more colours.
The present invention also teaches an improved process for reducing the
brittleness in enteric hard gelatin capsule by the following examples and
illustrations.
A series of experiments were designed with varying concentrations of
Triethyl citrate to optimize the correct desired concentration. Triethyl
citrate was used in 0.5, 1 .0, 1 .5, 2, 3, 4, 5, 6 and 7% addition level. The
brittleness was checked by standard brittleness checking equipment at 0
hr. 17 hrs., 24 hrs., 65 hrs. and 240 hrs. The capsules prepared with 1 to
2.5 % TEC did not become brittle and was having good mechanical
strength to run on the machines.
Triethyl citrate (TEC) finds use in this invention as mentioned herein:
Methacrylic acid polymer was added in ammoniated water and stirred for
complete dissolution. Triethyl citrate was added in the solution. The
entire mixture was homogenized, which was an important step, otherwise
the TEC floats on top and does not give uniform solution.
The containers of the present invention are made by the conventional dip
molding process. Other modified processes can also be used to make
the containers such as injection- moulding and the like.
In general the present invention suggests the use of 0.5% - 5% of triethyl
citrate for achievement of better stability in the hard gelatin capsules. Accelerated stability study shows that the capsules are stable at storage conditions of 40°C and 75%> relative humidity and room temperature for three months.
The following table explains the dissolution data of three months accelerated stability, performed with diclofenac sodium drug formulation filled in the enteric hard gelatin capsule.
Figure imgf000009_0001
The following examples enable a better understanding of the invention.
Example-1
Ingredients Composition
Methacrylic acid copolymer 7.86 g.
Water 53.70 g.
Ammonia solution ( 10 % v/v ) q.s
Propylene Glycol 1.96 g
Gelatin Solution ( 33.33% ) 40.00 g
To water add propylene glycol and ammonia solution under stirring. Add Eudragit slowly to above solution under stirring, de-aerate the solution on the water bath. Gelatin solution is added to the polymer solution under stirring at temp 52°C and deareate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Propylene glycol is a plasticizer and gives capsules that are not sturdy. The capsules were soft and pliable.
Example-2
Ingredients Composition
Methacrylic acid copolymer 13.79 g.
Water 60.00 g. Ammonia solution ( 25 % w/v ) q.s g.
Propylene Glycol 1 .00 g.
Gelatin Solution ( 33.33% ) 24.21 g.
To water add propylene glycol and ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring de- aerate the solution on the water bath. Gelatin solution is added to the polymer solution under stirring at temp 52°C and deareate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Propylene glycol is a plasticizer and gives capsules that are not sturdy. The capsules were soft and pliable.
Example-3
Ingredients Composition in g.
Methacrylic acid copolymer 13.79 Water 57.47
Ammonia solution ( 25 % w/v ) q.s
Propylene Glycol 3.45
Gelatin Solution ( 33.33% w/v ) 21 .83
To water add propylene glycol and ammonia solution under stirring. Add
Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Gelatin solution is added to the polymer solution under stirring at temp 52°C and deareate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Propylene glycol is a plasticizer and gives capsules that are not sturdy. The capsules were soft and pliable.
Example-4
Ingredients Composition in g.
Methacrylic acid copolymer 10.06
Water 56.54
Ammonia solution ( 25 % w/v ) q.s
Propylene Glycol 0.7 Triethyl citrate 5.10
Gelatin Solution ( 33.33% w/v ) 26.81
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Add propylene glycol and triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Propylene glycol is a plasticizer and gives capsules that are not sturdy. The capsules were soft and pliable.
Example-5
Ingredients Composition in g. Methacrylic acid copolymer 14.00
Water 45.00
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 0.5
Gelatin Solution ( 33.33% w/v ) 40.00
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and dearate the final solution at temp 52°C. Hard gelatin capsules are molded in- conventional dip molding process. Capsules were brittle.
Example-6
Ingredients Composition in g.
Methacrylic acid copolymer 14.00
Water ' 45.00
Ammonia solution ( 25 % w/v ) q.s Triethyl citrate 0.75
Gelatin Solution ( 33.33%> w/v ) 40.00
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and dearate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were brittle.
Example-7
Ingredients Composition in g.
Methacrylic acid copolymer 17.00 Water 46.00
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 0.5
Gelatin Solution ( 33.33% w/v ) 36.5
To water add ammonia solution under stirring.Add Methacrylic acid copolymer C slowly to above solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were brittle.
Example-8
Ingredients Composition in g.
Methacrylic acid copolymer 17.00
Water 46.00
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 1 .0 Gelatin Solution ( 33.33% w/v ) 36.00
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and dearate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were brittle after some time.
Example-9
Ingredients Composition in g.
Methacrylic acid copolymer 17.00
Water 46.00 Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 1 .5
Gelatin Solution ( 33.33% w/v ) 35.5
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle for 10 days. Example-10
Ingredients Composition in g.
Methacrylic acid copolymer 17.00
Water 46.00
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 2.0
Gelatin Solution ( 33.33% w/v ) 35.0
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle for 10 days and retained the mechanical strength.
Example-11
Ingredients Composition in g.
Methacrylic acid copolymer 17.00
Water 45.00
Ammonia solution ( 25 % w/v ) q.s Triethyl citrate 3.0
Gelatin Solution ( 33.33% w/v ) 35.00
To water add ammonia solution under stirring. Add Methacrylic acid copolymer C slowly to above solution under stirring de-aerate the solution on the water bath at temp 52°C . Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle , but they were very soft and were not sturdy to hold the medicaments.
Example-12
Ingredients Composition in g.
Methacrylic acid copolymer 17.00
Water 44.00
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 4.0 Gelatin Solution ( 33.33% w/v ) 35.00
To water add ammonia solution under stirring.Add Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle , but they were very soft and were not sturdy to hold the medicaments.
Example-13
Ingredients Composition in g.
Methacrylic acid copolymer 17.00 Water 43.00
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 5.0
Gelatin Solution ( 33.33% w/v ) 35.00
To water add ammonia solution under stirring.Add Methacrylic acid copolymer C slowly to above solution under stirring deareate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle , but they were very soft and were not sturdy to hold the medicaments.
Example-14
Ingredients Composition in g.
Methacrylic acid copolymer suspension 56.0
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 2.0
Gelatin Solution ( 33.33% w/v ) 42.00
To Methacrylic acid copolymer C Suspension slowly add ammonia solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process.
Example-15
Ingredients Composition in g.
Cellulose Acetate Phthalate 3.0
Water 36.0
Ammonia solution ( 25 % w/v ) q.s Triethyl citrate 1.0
Gelatin Solution ( 33.33% w/v ) 60.0
To water add ammonia solution under stirring. Add Cellulose Acetate Phthalate slowly to above solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring.
Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle for 10 days and retained the mechanical strength. But cellulose acetate phthalate (CAP) did not give good result in stability studies. Example-16
Ingredients Composition in g.
Cellulose Acetate Phthalate 6.0
Water 40.0
Ammonia solution ( 25 % w/v ) q.s
Triethyl citrate 1 .0
Gelatin Solution ( 33.33% w/v ) 53.0
To water add ammonia solution under stirring.Add Cellulose Acetate Phthalate slowly to above solution under stirring de-aerate the solution on the water bath. Add triethyl citrate to the polymer solution under stirring. Gelatin solution is added to the polymer solution under stirring at temp 52°C and de-aerate the final solution at temp 52°C. Hard gelatin capsules are molded in conventional dip molding process. Capsules were not brittle for 10 days and retained the mechanical strength.
Example 17
Ingredients Composition in g.
Gelatin solution ( 33.33%w/v) 35 g.
Methacrylic acid copolymer 17 g.
Water 30.5 g. Glycerin 10 g.
Ammonia solution ( 25%) q.s.
Triethyl citrate 7.5 g.
To water added glycerin and stirred until it mixes with water. Added ammonia and stirred. Added methacrylic acid copolymer to the above and de-aerated the solution for overnight at temperature 40 deg. C. Added triethyl citrate to the above and stirred well. Added gelatin solution to the above solution. This solution was taken for hard capsule dip molding process. The viscosity was very high and the hard capsules were not formed. Very soft capsules were formed that are not sturdy. This combination was not found suitable for dip molding process of capsules.
Example 18
Ingredients Composition in g
Sodium carbonate 10 g.
Water 100 ml.
Methacrylic acid copolymer 15 g. Gelatin solution ( 33.33%, w/v) 100 ml
Added water to sodium carbonate and mixed well. Added methacrylic acid copolymer to the above and stirred. Gelatin solution was added to above solution and mixed well. De-aerated the solution at 40 deg. C on a water bath. Films were prepared before dip molding the capsules to check the disintegration properties. The films were not stable at gastric pH and disintegrated completely at 25 mins. This composition was not found suitable to retain enteric properties.
Example 19
Ingredients Composition in g
Sodium - Bicarbonate 19 g.
Water 190 ml.
Methacrylic acid copolymer 38 g.
Gelatin solution ( 33.33%) w/v) 53 ml
Added water to sodium bicarbonate and mixed, well. Added methacrylic acid copolymer to the above and stirred. Gelatin solution was added to above solution and mixed well. De-aerated the solution at 40 deg. C on a water bath. Films were prepared before dip molding the capsules to check the disintegration properties. The films did not disintegrate in gastric pH for 2 hrs. This passes the enteric test. The films were soft without any brittleness. Example 20
Ingredients Composition in g
Methacrylic acid copolymer 6 g.
Isopropyl alcohol 85 ml
Water 5 ml
Triethyl citrate 0.6 g.
Added methacrylic acid copolymer into isopropyl alcohol and dissolved . Added water and TEC and stirred well. Films were made with this solution
. Films were not brittle and were very elastic with no mechanical strength. Added gelatin solution to give mechanical strength , but there was an incompatibility and gelatin precipitated out in the solvent.
Example 21
Ingredients Composition in g.
Hydroxypropyl methyl cellulose phthalate 10 g.
Water 50 ml. Ammonia solution ( 25 % ) 3 ml
Gelatin solution ( 33.33 % w/v) 15 ml
Carrageenan ( gelling aid ) 0.12 g.
Potassium chloride 0.04 g.
HPMCP was dispersed in water and ammonia was added to solubilise it.
Carrageenan and potassium chloride was added and gelatin solution was added to the above. A film was prepared to check the disintegration properties. The film was very BRITTLE and did not dissolve in gastric pH for 2 hours. Example 22
Ingredients Composition in g.
Hydroxypropylmethyl cellulose phthalate 10 g.
Water 50 ml.
Ammonia solution ( 25 % ) 3 ml
Gelatin solution ( 33.33 % w/v) 15 ml
Carrageenan ( gelling aid ) 0.4 g.
Potassium chloride 0.04 g.
HPMCP was dispersed in water and ammonia was added to solubilise it. Carrageenan and potassium chloride was added and gelatin solution was added to the above. A film was prepared to check the disintegration properties. The film was very BRITTLE and did not dissolve in gastric pH for 2 hours.
Example 23
Ingredients Composition in g. Hydroxypropylmethyl cellulose phthalate 10 g.
Water 60 ml.
Ammonia solution ( 25 % ) 3 ml
Gelatin solution ( 33.33 % w/v) 15 ml
Carrageenan ( gelling aid ) 0.5 g. Potassium chloride 0.04 g.
HPMCP was dispersed in water and ammonia was added to solubilise it. Carrageenan and potassium chloride was added and gelatin solution was added to the above. A film was prepared to check the disintegration properties. The film was very BRITTLE and did not dissolve in gastric pH for 2 hours. Study of Brittleness of Enteric capsules with different concentrations of Triethyl citrate.
Figure imgf000021_0001
Brittleness is checked by Brittleness Rod
Brittleness: Take 100 capsule shells devoid of long short, broken or separated ones, place each shell on a smooth hard surface. Using a brass rod of 150mm length and 25 mm diameter and weighing approximately 0.5 kg, press the entire length of the shell until the sides meet. Repeat with another 99 shells. Not more than two shells crack, ship or break. If more than two but less than six shells fail to comply with the test, repeat the test with another 100 shells taken at random. The sample being examined if not more than six out of 200 shells fail to comply with the test.

Claims

1. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same comprising the steps of:
(a). neutralizing enteric polymer slowly in alkaline solution under stirring,
(b) de-aerating the solution on the water bath,
(c) adding plasticizer to the polymer solution under stirring and
homogenized,
(d) adding gelatin solution to the polymer solution under stirring
at desired temperature,
(e) de-aerating the final solution at desired temperature,
(f) dipping and molding the capsule by conventional process
known in the art.
2. A novel pH dependent robust enteric polymeric container without
coating comprising a body and a cap such as hard capsules and the like
and a process of manufacturing the same as claimed in claim 1 wherein;
(a) the alkaline solution used for neutralizing enteric polymer is
prepared by adding water to a base like ammonia, sodium
carbonate, sodium bicarbonate, sodium hydroxide and the
like under stirring.
(b) the enteric copolymer is selected in the range of 1 % to 60%. (c ) the plasticizer is selected in the range of 0.5% to 7%, preferably 1 % to 5%. (d) aqueous gelatin solution in the range of 3% to 35%, preferably 5% to 25%.
(e) adding gelatin solution at a temperature in the range of 45 degree centigrade to 55 degree centigrade, preferably between 46 degree centigrade and 52 degree centigrade.
3. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 1 wherein the enteric polymer is selected from a group consisting of methacrylic acid copolymer in the range of 5% w/w to 60% w/w, preferably 8% to 20%; a more preferably 12 to 18%. Cellulose acetate phthalate in the range of 2% to 12%, preferably 3% to 8%; hydroxypropyl methylcellulose phthalate in the range of 1 % to 20%, polyvinyl acetate phthalate and other gastro resistant polymers and the like and combinations thereof, in powdered form or in suspension form.
4. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 1 wherein
the plasticizer is selected from a group comprising triethyl citrate
dibutyl phthalate, diethyl phthalate, benzyl phenylformate, sorbitol,
polyethylene glycol, and the like and combinations thereof.
5. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 1 wherein the plasticizer is triethyl citrate.
6. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 1 wherein the container is a capsule.
7. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 1 wherein the container may optionally include colourants, surfactants, opacifiers, silicon dioxide, preservatives, sweeteners, flavours, and the like.
8. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 1 wherein the container may or may not be sealed.
9. A process for manufacturing novel pH dependent robust enteric
polymeric container without coating such as hard capsule as claimed in
claim 1 wherein the container may optionally be printed axially and/or
radially in one or more colours.
10. A novel pH dependent robust enteric polymeric container without
coating comprising a body and a cap such as hard capsules and the like
and a process of manufacturing the same as claimed in claim 5 wherein
triethyl citrate is selected in the range 1 to 5%.
11. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 5 & 10 wherein triethyl citrate is selected preferably in the range 1 to 2.5%.
12. A novel pH dependent robust enteric polymeric container without coating comprising a body and a cap such as hard capsules and the like and a process of manufacturing the same as claimed in claim 5 & 10 wherein triethyl citrate is selected more preferably in the range 2%.
13. A novel pH dependent robust enteric polymeric container without coating and a process as claimed in claim 3 wherein Methacrylic acid copolymer is either in suspension form or in the form of powder.
14. A novel pH dependent robust enteric polymeric container without coating and a process for preparing the same as claimed in claim 3 and 13 wherein Methacrylic acid copolymer can be substituted by Hydroxypropyl methylcellulose phthalate (HPMCP), Cellulose Acetate
Phthalate (CAP) and the like with or without gelling agent.
15. An enteric polymeric container made by the process as claimed in claim 1 to 14.
PCT/IN2003/000263 2002-08-02 2003-08-01 NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS. WO2004012701A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003274683A AU2003274683A1 (en) 2002-08-02 2003-08-01 NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US691/MUM/2002 2002-08-02
US6912002 2002-08-02

Publications (2)

Publication Number Publication Date
WO2004012701A2 true WO2004012701A2 (en) 2004-02-12
WO2004012701A3 WO2004012701A3 (en) 2004-03-25

Family

ID=36118207

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2003/000263 WO2004012701A2 (en) 2002-08-02 2003-08-01 NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.

Country Status (2)

Country Link
AU (1) AU2003274683A1 (en)
WO (1) WO2004012701A2 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2223685A1 (en) * 2007-11-13 2010-09-01 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin enteric hard capsule shell and preparation method thereof
WO2011048388A3 (en) * 2009-10-22 2011-06-30 Probio Asa Oral pharmaceutical and nutraceutical compositions
WO2013188681A1 (en) * 2012-06-14 2013-12-19 Microvention, Inc. Polymeric treatment compositions
EP2772250A1 (en) * 2002-10-01 2014-09-03 Banner Pharmacaps, Inc. Enteric composition for the manufacture of soft capsule wall
US9254270B2 (en) 2002-10-01 2016-02-09 Banner Life Sciences Llc Enteric soft capsules
JP2016517422A (en) * 2013-03-15 2016-06-16 バナー ライフ サイエンシズ リミティド ライアビリティ カンパニー Non-gelatin enteric soft capsule
US9775814B2 (en) 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
EP3272341A1 (en) * 2016-03-30 2018-01-24 Gdanski Uniwersytet Medyczny Enteric elastic films for the production of capsules
US10525010B2 (en) 2012-05-02 2020-01-07 Capsugel Belgium Nv Aqueous dispersions of controlled release polymers and shells and capsules thereof
US10813886B2 (en) 2013-11-04 2020-10-27 Capsugel Belgium Nv Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
EP0056825A1 (en) * 1981-01-22 1982-08-04 Capsugel A.G. A process for producing a pharmaceutical capsule having enteric properties
DE3222476A1 (en) * 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Soft gelatin capsules resistant to gastric fluid, and process for the production thereof
WO2001024780A2 (en) * 1999-10-01 2001-04-12 Natco Pharma Limited Soft gel capsule resistant to gastric juices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6216432A (en) * 1985-07-05 1987-01-24 Shin Etsu Chem Co Ltd Enteric coating composition

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138013A (en) * 1976-08-27 1979-02-06 Parke, Davis & Company Enteric capsules
EP0056825A1 (en) * 1981-01-22 1982-08-04 Capsugel A.G. A process for producing a pharmaceutical capsule having enteric properties
DE3222476A1 (en) * 1982-06-15 1983-12-15 Warner-Lambert Co., 07950 Morris Plains, N.J. Soft gelatin capsules resistant to gastric fluid, and process for the production thereof
WO2001024780A2 (en) * 1999-10-01 2001-04-12 Natco Pharma Limited Soft gel capsule resistant to gastric juices

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN vol. 011, no. 193 (C-430), 20 June 1987 (1987-06-20) & JP 62 016432 A (SHIN ETSU CHEM CO LTD), 24 January 1987 (1987-01-24) cited in the application *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433585B2 (en) 2002-10-01 2016-09-06 Banner Life Sciences Llc Enteric soft capsules
EP2772250A1 (en) * 2002-10-01 2014-09-03 Banner Pharmacaps, Inc. Enteric composition for the manufacture of soft capsule wall
US9254270B2 (en) 2002-10-01 2016-02-09 Banner Life Sciences Llc Enteric soft capsules
EP2223685A4 (en) * 2007-11-13 2013-08-21 Shanghai Huiyuan Vegetal Capsule Co Ltd Non-gelatin enteric hard capsule shell and preparation method thereof
EP2223685A1 (en) * 2007-11-13 2010-09-01 Shanghai Huiyuan Vegetal Capsule Co., Ltd Non-gelatin enteric hard capsule shell and preparation method thereof
WO2011048388A3 (en) * 2009-10-22 2011-06-30 Probio Asa Oral pharmaceutical and nutraceutical compositions
US10525010B2 (en) 2012-05-02 2020-01-07 Capsugel Belgium Nv Aqueous dispersions of controlled release polymers and shells and capsules thereof
WO2013188681A1 (en) * 2012-06-14 2013-12-19 Microvention, Inc. Polymeric treatment compositions
JP2016517422A (en) * 2013-03-15 2016-06-16 バナー ライフ サイエンシズ リミティド ライアビリティ カンパニー Non-gelatin enteric soft capsule
EP2968081A4 (en) * 2013-03-15 2016-08-10 Banner Life Sciences Llc Non-gelatin enteric soft capsules
US10813886B2 (en) 2013-11-04 2020-10-27 Capsugel Belgium Nv Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
US9775814B2 (en) 2014-06-20 2017-10-03 Patheon Softgels Inc. Enteric soft capsule compositions
US10226432B2 (en) 2014-06-20 2019-03-12 Patheon Softgels Inc. Enteric soft capsule compositions
EP3272341A1 (en) * 2016-03-30 2018-01-24 Gdanski Uniwersytet Medyczny Enteric elastic films for the production of capsules

Also Published As

Publication number Publication date
AU2003274683A1 (en) 2004-02-23
WO2004012701A3 (en) 2004-03-25
AU2003274683A8 (en) 2004-02-23

Similar Documents

Publication Publication Date Title
US10874619B2 (en) Acid resistant capsules
JP4780898B2 (en) Pectin film composition
RU2528095C2 (en) Systems of film coating for preparations with immediate release, creating enhanced anti-moisture barrier, and substrates with such coating
EP1545475B1 (en) Enteric composition for the manufacture of soft capsule wall
JP2650578B2 (en) Gelatin film composition for hard capsule and easily soluble hard gelatin capsule
EP2283830A1 (en) Aqueous enteric capsule coating
TWI539976B (en) Composition for enteric hard capsules, and enteric hard capsule prepared using the composition
WO2004012701A2 (en) NOVEL pH DEPENDENT ROBUST ENTERIC POLYMERIC CONTAINER, AN IMPROVEMENT OVER EXISTING ENTERIC DOSAGE FORMS.
US20110206763A1 (en) Rapid-release encapsulation composition
US11904056B2 (en) Capsule shell comprising a core-shell polymer and a cellulose
JPH0380930A (en) Composition of gelatin coating
JP4916163B2 (en) Capsule coating agent
CN118384131A (en) Controlled release capsule
WO2022244713A1 (en) Non-gelatin hard capsule and method for producing same
JPH1149667A (en) Hard gelatin capsule

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase in:

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP